Cardiovascular adverse events associated with oral antineoplastic therapy

Silva, Jacqueline Mota da; Lima, Beatriz da Silva; Araújo, Thelma Leite de; Lima, Francisca Elisângela Teixeira; Cunha, Gilmara Holanda da.
Rev. bras. enferm ; 71(5): 2561-2569, Sep.-Oct. 2018. tab, graf
Artigo em Inglês | LILACS, BDENF | ID: biblio-958723

Documentos relacionados

  1. Brassica-derived isothiocyanates as anticancer therapeutic agents and their nanodelivery.
  2. 3-Heptylidene-4,6-Dimethoxy-3<i>H</i>-Isobenzofuran-1-One Is Genotoxic, Increases the Frequency of Cell Death, and Potentiates the Effects of Cyclophosphamide and Cisplatin.
  3. Apigenin as an anticancer agent.
  4. Anticarcinogenic Effects of Isothiocyanates on Hepatocellular Carcinoma.
  5. Updated Review on the Role of Curcumin in Gastrointestinal Cancers.
  6. Natural Polyphenols for Treatment of Colorectal Cancer.
  7. Chemopreventive Synergism between Green Tea Extract and Curcumin in Patients with Potentially Malignant Oral Disorders: A Double-blind, Randomized Preliminary Study.
  8. Cardiovascular adverse events associated with oral antineoplastic therapy.
  9. Anticarcinogenic Effects of &#945;-Mangostin: A Review.
  10. SYNTHESIS AND CYTOTOXIC EVALUATION OF SOME 2-{4-[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL] PHENOXY}-N-PHENYLACETAMIDE.